99 related articles for article (PubMed ID: 4079019)
21. [Clinical study of SM-4300 in infectious diseases of pediatrics].
Mikuni K; Hoshina H; Ichihashi H
Jpn J Antibiot; 1985 Sep; 38(9):2587-93. PubMed ID: 4079024
[TBL] [Abstract][Full Text] [Related]
22. [Clinical study on SM-4300 in the field of internal medicine].
Tomii M; Kobayashi Y; Fujimori I
Jpn J Antibiot; 1985 Sep; 38(9):2503-8. PubMed ID: 3935825
[TBL] [Abstract][Full Text] [Related]
23. [Clinical evaluation of SM-4300 against bacterial infections in the field of internal medicine].
Yamakido M; Takami S; Nohmi K; Sadamoto K
Jpn J Antibiot; 1985 Sep; 38(9):2532-4. PubMed ID: 3866098
[TBL] [Abstract][Full Text] [Related]
24. [Clinical study on unmodified intravenous dried ion-exchange resin treated human normal immunoglobulin, SM-4300].
Shimada J; Fujimaki H; Kuriyama S; Aizawa S; Karashima H; Yoshida M; Miyahara T
Jpn J Antibiot; 1985 Sep; 38(9):2496-502. PubMed ID: 4079016
[TBL] [Abstract][Full Text] [Related]
25. [Laboratory and clinical studies on SM-4300 in the pediatric field].
Takashima T; Tabuki K; Nishimura T; Takagi M
Jpn J Antibiot; 1985 Sep; 38(9):2594-602. PubMed ID: 3935828
[TBL] [Abstract][Full Text] [Related]
26. [Clinical trial of SM-4300 in the pediatric field].
Motohiro T; Tanaka K; Shimada Y; Tomita N; Sakata Y; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Sakaguchi Y
Jpn J Antibiot; 1985 Sep; 38(9):2603-11. PubMed ID: 4079025
[TBL] [Abstract][Full Text] [Related]
27. [Clinical studies of SM-4300 in children].
Nagamatsu I; Sato Y; Miyanoshita A; Abe K
Jpn J Antibiot; 1985 Sep; 38(9):2565-70. PubMed ID: 3935827
[TBL] [Abstract][Full Text] [Related]
28. [Therapeutic evaluation of combination therapy using C-425, human native immunoglobulin liquid preparation for i.v. administration, with antibiotics in severe infections in the field of internal medicine].
Kitamura K; Takaku F; Miyazaki T; Wakui A; Mizoguchi H; Uchino H; Masaoka T; Nagai K; Niho Y
Kansenshogaku Zasshi; 1990 Jan; 64(1):19-33. PubMed ID: 2186159
[TBL] [Abstract][Full Text] [Related]
29. [Clinical studies on SM-4300, a new intravenous human gamma-globulin].
Nakatomi M; Terukina S; Oyakawa T; Kinjo Y
Jpn J Antibiot; 1985 Sep; 38(9):2542-6. PubMed ID: 3935826
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic evaluation of combination therapy using C-425, human native immunoglobulin liquid preparation for i.v. administration, and antibiotics in severe and/or refractory infections in pediatrics].
Nishimura T; Fujii R; Abe T; Meguro H; Hiruma F; Hori M; Tatsuzawa O; Maekawa K; Wada N; Kubo M
Kansenshogaku Zasshi; 1990 Jan; 64(1):34-53. PubMed ID: 2186160
[TBL] [Abstract][Full Text] [Related]
31. [Combined effect of intravenous human immunoglobulin (GV-523) and antibiotics in severe infections in the fields of internal medicine and surgery].
Mashimo K
Kansenshogaku Zasshi; 1983 Aug; 57(8):724-49. PubMed ID: 6420484
[No Abstract] [Full Text] [Related]
32. [Therapeutic evaluation of combination therapy using C-425, human native immunoglobulin liquid preparation for i.v. administration, with antibiotics in severe infections in the field of surgery].
Mishima Y; Inoue T; Hayasaka H; Totsuka M; Ebata T; Motoki R; Inoue H; Endo Y; Tamakuma S; Imai J
Kansenshogaku Zasshi; 1990 Jan; 64(1):54-64. PubMed ID: 2186161
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic effects of SM-4300 and antibiotic combinations against severe bacterial infections in the field of internal medicine].
Hara K; Saito A; Yamaguchi K; Suzuyama Y; Shigeno Y; Koga H; Iwasaki H; Koteda T; Okuno K; Ikebe A
Kansenshogaku Zasshi; 1984 Oct; 58(10):982-1000. PubMed ID: 6442324
[No Abstract] [Full Text] [Related]
34. [Therapeutic effects of cefoxitin in the treatment of various infections in children (author's transl)].
Wakiguchi H; Ozaki H; Nishibayashi Y; Hamawaki M; Kurashige T; Kitamura I
Jpn J Antibiot; 1981 Mar; 34(3):374-83. PubMed ID: 7289030
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic effects of SM-4300, antibiotics combinations against severe bacterial infections in the field of surgery].
Sakai K
Kansenshogaku Zasshi; 1984 Dec; 58(12):1315-28. PubMed ID: 6442726
[No Abstract] [Full Text] [Related]
36. [Clinical evaluation on SM-4300 for severe infections complicated with hematological disorders--a comparative study with cross-over method].
Shiku H; Yamada K; Kobayashi M; Ino T; Hirano M; Suzuki S; Nitta M; Mitomo Y; Sugihara T; Ohno R
Kansenshogaku Zasshi; 1984 Dec; 58(12):1338-51. PubMed ID: 6442728
[No Abstract] [Full Text] [Related]
37. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
Kaneko H; Masaki T; Yamaguchi R; Takahashi N; Umeda M; Shirai T
Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
[TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
Ito A; Maruta I; Ogawa K; Asada H; Matsuzaki M
Jpn J Antibiot; 1985 Aug; 38(8):2108-18. PubMed ID: 4079002
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic and therapeutic use of immunoglobulin for intravenous administration in patients with secondary immunodeficiencies associated with malignancies.
Morell A; Barandun S
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S87-91. PubMed ID: 2840630
[TBL] [Abstract][Full Text] [Related]
40. [Clinical investigation of cefotiam against infections complicated by acute leukemia].
Tsuchiya J; Murakami H; Okamoto K; Nemoto K; Omine M; Maekawa T
Jpn J Antibiot; 1982 May; 35(5):1167-71. PubMed ID: 6290701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
